S550-0266 Screening compound: 2-(3-methylphenoxy)-N-({8-[3-(propan-2-yl)-1,2,4-oxadiazol-5-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl}methyl)acetamide

S550-0266 Screening compound: 2-(3-methylphenoxy)-N-({8-[3-(propan-2-yl)-1,2,4-oxadiazol-5-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl}methyl)acetamide
S550-0266 Screening compound: 2-(3-methylphenoxy)-N-({8-[3-(propan-2-yl)-1,2,4-oxadiazol-5-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl}methyl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S550-0266
2-(3-methylphenoxy)-N-({8-[3-(propan-2-yl)-1,2,4-oxadiazol-5-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl}methyl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S550-0266

Molecular Formula

C21H22N6O3 (C21 H22 N6 O3)

Compound Name

2-(3-methylphenoxy)-N-({8-[3-(propan-2-yl)-1,2,4-oxadiazol-5-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl}methyl)acetamide

IUPAC name

2-(3-methylphenoxy)-N-({8-[3-(propan-2-yl)-124-oxadiazol-5-yl]-[124]triazolo[43-a]pyridin-3-yl}methyl)acetamide

SMILES

CC(C)c1noc(-c2cccn3c2nnc3CNC(COc2cc(C)ccc2)=O)n1

InChI

InChI=1S/C21H22N6O3/c1-13(2)19-23-21(30-26-19)16-8-5-9-27-17(24-25-20(16)27)11-22-18(28)12-29-15-7-4-6-14(3)10-15/h4-10,13H,11-12H2,1-3H3,(H,22,28)

InChI Key

WRNKIZJSZFDLJA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD28994398

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

406.44

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.551

Distribution Coefficient, logD

2.551

Water Solubility, LogSw

-2.90

Polar Surface Area

86.748

Acid Dissociation Constant (pKa)

12.89

Base Dissociation Constant (pKb)

1.61

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

S550-0266 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with S550-0266 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S550-0266?
Check Price and Availability of S550-0266, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S550-0266 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S550-0266
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S550-0266
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S550-0266 available by request